Bradford Graves
ScholarGPS® ID: 30670687980018
Affiliation History
Discipline
Chemistry
Top Specialties
Medicinal Chemistry | Crystal Structure | Influenza | Peptide
Metrics Summary
Publication Count
39
Predicted Citations
10,732
Predicted h-index
28
Ranking
Publications and Citation History
Publications based on Top Specialties
Types of Publication
- Publications
- Books
- Patents
- NIH/NSF
Add
Delete
|
---|
Discovery of Sulanemadlin (ALRN-6924), the First Cell-Permeating, Stabilized α-Helical Peptide in Clinical Development (journal article) Journal of Medicinal Chemistry, volume 66, issue 14, pages 9401-9417 (2023). |
Discovery of potent and selective spiroindolinone MDM2 inhibitor, RO8994, for cancer therapy (journal article) Bioorganic & Medicinal Chemistry, volume 22, issue 15, pages 4001-4009 (2014). |
Discovery of Potent and Orally Active p53-MDM2 Inhibitors RO5353 and RO2468 for Potential Clinical Development (journal article) ACS Medicinal Chemistry Letters, volume 5, issue 2, pages 124-127 (2014). |
Discovery of RG7388, a Potent and Selective p53–MDM2 Inhibitor in Clinical Development (journal article) Journal of Medicinal Chemistry, volume 56, issue 14, pages 5979-5983 (2013). |
Deconstruction of a Nutlin: Dissecting the Binding Determinants of a Potent Protein–Protein Interaction Inhibitor (journal article) ACS Medicinal Chemistry Letters, volume 4, issue 7, pages 660-665 (2013). |
ACS Medicinal Chemistry Letters, volume 4, issue 5, pages 466-469 (2013). |
MDM2 Small-Molecule Antagonist RG7112 Activates p53 Signaling and Regresses Human Tumors in Preclinical Cancer Models (journal article) Cancer Research, volume 73, issue 8, pages 2587-2597 (2013). |
The Lancet Oncology, volume 13, issue 11, pages 1133-1140 (2012). |
Activation of the p53 pathway by small-molecule-induced MDM2 and MDMX dimerization (journal article) Proceedings of the National Academy of Sciences, volume 109, issue 29, pages 11788-11793 (2012). |
Patent Number: 7851626 (2010) |
Journal of Medicinal Chemistry, volume 49, issue 22, pages 6549-6560 (2006). |
Optimization of Small Molecule Drugs Binding to Highly Polar Target Sites: Lessons from the Discovery and Development of Neuraminidase Inhibitors (journal article) Current Topics in Medicinal Chemistry, volume 6, issue 5, pages 423-434 (2006). |
Small Molecule Inhibitors of p53/MDM2 Interaction (journal article) Current Topics in Medicinal Chemistry, volume 5, issue 2, pages 159-165 (2005). |
Development of E3‐Substrate (MDM2‐p53)–Binding Inhibitors: Structural Aspects (book chapter) In Ubiquitin and Protein Degradation, Part B Elsevier (2005) |
Science, volume 303, issue 5659, pages 844-848 (2004). |
ChemInform Abstract: Carbocyclic Influenza Neuraminidase Inhibitors Possessing a C3 ‐Cyclic Amine Side Chain: Synthesis and Inhibitory Activity. (journal article) ChemInform, volume 31, issue 39 (2000). |
Carbocyclic influenza neuraminidase inhibitors possessing a C 3 -cyclic amine side chain: synthesis and inhibitory activity (journal article) Bioorganic & Medicinal Chemistry Letters, volume 10, issue 11, pages 1257-1260 (2000). |
ChemInform Abstract: Synthesis and Evaluation of 1,4,5,6‐Tetrahydropyridazine Derivatives as Influenza Neuraminidase Inhibitors. (journal article) ChemInform, volume 30, issue 43 (1999). |